PO Box 1488
Warrenville, IL 60555
Phone: 331.248.7888
Email: sidp@affinity-strategies.com
Erin McCreary (@erinmccreary) discusses clinical rationale behind therapeutic drug monitoring of beta-lactam antibiotics with Veena Venugopalan (@Veena_PharmD), Joseph Kuti, Jason Roberts (@jasonroberts_pk), and Marc Scheetz (IDPharmacometrx).
For BCIDP credit, visit
https://sidp.org/BCIDP
References:
1. https://pubmed.ncbi.nlm.nih.gov/32383061/
2. https://clicktime.symantec.com/3BcGw6g11AZY2rSUu7KpT1D7Vc?u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34136822%2F
3. https://pubmed.ncbi.nlm.nih.gov/33480024/
4. https://pubmed.ncbi.nlm.nih.gov/32910809/
Veena Venugopalan, PharmD, BCIDP
Dr Venugopalan, is a Clinical Associate professor in the department of pharmacotherapy and translational therapy at the University of Florida College of Pharmacy. Her research interests include multidrug resistant Gram-negative infections and healthcare associated infections. Several of her publications have investigated the role of therapeutic drug monitoring in these areas. She also practices as an infectious diseases clinical specialist at the University of Florida Health Shands Hospital
Joseph Kuti, PharmD, FIDP, FCCP
Dr. Kuti is the Associate Director of Clinical and Economic Studies at the Center for Anti-infective Research and Development at Hartford Hospital. His research interests include pharmacokinetics and pharmacodynamics and his work has contributed to over 200 peer reviewed publications.
Jason Roberts, PhD, B Pharm (Hons), B App Sc, FSHP
Professor Roberst is an ICU pharmacist at the Royal Brisbane and Women’s Hospital and Australian National Health and Medical Research Council practitioner fellow at the University of Queensland. His primary research interest is in optimization of antimicrobial dosing in the critically ill population. He was involved in one of the first centers to develop a formal beta-lactam therapeutic drug monitoring service.
Marc Scheetz, PharmD, MSc, FCCP, FCP, FIDSA
Dr. Scheetz is a Professor and Director of the Pharmacometrics Center of Excellence at Midwestern University in Chicago. His research interests include the interaction between pharmacokinetics and pharmacodynamics and optimizing drug exposure as it relates to both efficacy and toxicity. He also practices as an infectious diseases pharmacist at Northwestern Memorial Hospital
